Is Redhill Biopharma (RDHL) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 05/15/20
RedHill's Covid-19 Program On Track, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 05/10/20
RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.GlobeNewsWire • 05/08/20
RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal MedicineGlobeNewsWire • 05/05/20
Is Redhill Biopharma (RDHL) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 04/28/20
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National FormularyGlobeNewsWire • 04/28/20
RedHill Biopharma Announces Agreement with NIAID to Evaluate RHB-107 Against COVID-19GlobeNewsWire • 04/20/20
Additional Update on COVID-19 Compassionate Use with Opaganib in Israel Provided by RedHill BiopharmaGlobeNewsWire • 04/17/20
RedHill Biopharma Provides Initial Update from its Opaganib COVID-19 Compassionate Use Program in IsraelGlobeNewsWire • 04/13/20
RedHill Biopharma Announces Approval of Compassionate Use of Opaganib for COVID-19 in ItalyGlobeNewsWire • 04/06/20
RedHill Biopharma Announces First COVID-19 Patient Treated with Opaganib in Israel Under Compassionate UseGlobeNewsWire • 04/06/20
RedHill Biopharma Announces Preferred Position for Talicia® on Express Scripts National Preferred Formulary Effective March 13, 2020GlobeNewsWire • 03/13/20
RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/04/20